NCT06701812 2026-02-27
Digoxin Medulloblastoma Study
H. Lee Moffitt Cancer Center and Research Institute
Phase 2 Recruiting
Clinical Trials
6 trialsNCT04141995 2025-08-07
FOLFIRINOX With Digoxin in Patients With Resectable Pancreatic Cancer
University of Nebraska
Phase 2 Terminated
NCT01162135 2025-05-04
Digoxin for Recurrent Prostate Cancer
Thomas Jefferson University
Phase 2 Completed
NCT01763931 2020-01-31
DIG-HIF-1 Pharmacodynamic Trial in Newly Diagnosed Operable Breast Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 2 Completed
NCT00281021 2018-03-29
Second Line Erlotinib (Tarceva) Plus Digoxin in Non-Small Cell Lung Cancer
University of Louisville
Phase 2 Terminated
NCT01887288 2018-02-22
Capecitabine With Digoxin for Metastatic Breast Cancer
Western Regional Medical Center
Phase 2 Terminated